Peptic Ulcer Disease Flashcards
H. pylori pathophysiology
Colonizes the mucus layer of the gut
H. Pylori is adapted survive in low gastric pH via production of urease
Eventually penetrates mucus layer to adhere to gastric epithelial cells
Years of chronic inflammation → damaged gastric epithelium → normal gastric tissue replaced by intestinal-type mucosa (intestinal metaplasia) - thought to be a precursor to gastric adenocarcinoma
H. pylori causes the majority of ______
Duodenal and gastric ulcers
H. pylori also associated with
Chronic gastritis
Mucosa-associated lymphoid tissue lymphoma (MALToma)
Gastric adenocarcinoma
Indications for testing for H. pylori
Current guidelines recommend treatment for H. pylori whenever it is detected – so only test if you plan to treat if positive
Indications for Testing: Patients with MALToma of Malt lymphoma Active peptic ulcer disease H/o peptic ulcer without documented cure of H. pylori infection Early gastric cancer Patients with dyspepsia
When should you test vs empiric treatment for H. pylori
Testing: Dyspepsia in patients <60* yo without alarm sxs (pts with alarm symptoms or ≥60* yo with new onset dyspepsia should have EGD)
Unexplained iron deficiency
Recurrent idiopathic thrombocytopenia
Empiric treatment: Peptic ulcer disease
MALToma
Atrophic gastritis
H. pylori alarm symptoms
Unexplained weight loss Dysphagia Recurrent vomiting Early satiety Digestive bleeding Anemia
H. pylori referral for endoscopy
Patients ≥60* with dyspepsia (*previously 55)
Pts with alarm symptoms (unexplained weight loss, dysphagia, recurrent vomiting, early satiety or digestive bleeding or anemia)
Biopsy specimens can then be tested for urease and also examined histologically for H. pylori infection and its lesions
H. pylori testing for patients NOT undergoing EGD
Urea breath test
Stool antigen assay: Patient should be off acid supression for at least 2 weeks prior
H. pylori first line treatment
**Need to know
Triple therapy
PPI BID + clarithromycin + amoxicillin for 7-14 days (in PCN allergic pts, substitute metronidazole for amoxicillin)
H. pylori second line
treatment
**Need to know
Quadruple therapy (reserved for patients that fail first line treatment) (After first-line failure; patients who fail first-line treatment should have H. pylori susceptibility testing done prior to starting second-line treatment)
This regimen is also used as first line Rx in areas of high clarithromycin resistance and in pts with recent or repeated exposure to clarithromycin
PPI BID + metronidazole + bismuth subsalicylate (Pepto-Bismol) + tetracycline for 14 days
H. pylori follow up treatment
All patients should receive follow up to confirm eradication. (At least 4 weeks after starting treatment and remember to d/c PPI 2 weeks before)
Urea breath test is preferred but can also do stool antigen.
Gastritis
Inflammation of the gastric mucosa; can be acute or chronic
Etiologies: H. pylori and other infections NSAIDs Drinking alcohol Autoimmune disorders Critical illness
Peptic ulcer disease (PUD)
Refers to both gastric or duodenal ulcers
Ulcer is a disruption in the mucosal integrity of the stomach and or duodenum > 5mm in size due to inflammation.
What are the two major factors associated with PUD?
- H. Pylori infection
2. Consumption of NSAIDs
PUD: NSAIDs
Associated with increased risk of complications from PUD
Mucosal damage by ASA and NSAIDs due to inhibition of COX-1 in upper GI tract
COX-1 is an enzyme that plays a key role in the protection of the gastrointestinal tract from the acidic environment of the stomach
Cox-1 is responsible for production of prostaglandins
Prostaglandins (such asPGE2) are in turn responsible for production of mucus and bicarbonate by the gastric cell lining
COX-1 inhibition reduces mucosal generation of protective prostaglandins
This can lead to formation of ulcers. Development of GI symptoms in patients taking NSAIDs should prompt evaluation.
Patients at increased risk for NSAID GI toxicity
High risk: Hx of previous ulcer
Multiple risk factors
Moderate risk: Age > 65
High dose NSAID
Hx of uncomplicated ulcer
Concurrent use of ASA, steroids, and anticoagulants.
Stress ulcers
Severe physiologic stress can lead to the development of PUD
Stress ulcers commonly seen in patients hospitalized for acute medical or surgical illnesses – especially in the ICU and on ventilator
Etiology is unclear